Code | Vaccine | Type | Possible long term effects1 | Vaccination Requirements & Comments |
VA 1 | B.C.G. (Tuberculosis) | live attenuated | TB, ME | In UK at age 12-13 |
VA 2 | Cholera | killed organisms | severe allergic reactions to vaccine, nerve damage, mental problems | vaccination only recommended if travelling to cholera areas across remote borders, especially overland. |
VA 3 | D.P.T. (Diphtheria, Whooping Cough, Tetanus) | toxoids of diphtheria & tetanus; inactivated pertussis | sudden infant death syndrome, brain damage, asthma | introduced in 1957 in UK, by 1969 over 80% of children vaccinated recommended regime is 4 times before age 6 and then age 14-16 years old, and then every 10 years afterwards |
VA 4 | Diphtheria | inactivated bacterial toxins | | introduced in 1930’s, now mainly given as DPT |
VA 5 | Diphtheria/Tetanus | inactivated bacterial toxins | | now mainly given as DPT |
VA 6 | Encephalitis | inactivated | | travel vaccination for Far East, Indian subcontinent, South East Asia |
VA 7 | Hepatitis A | | | travel vaccination |
VA 8 | Hepatitis B | genetic engineering (yeast or plasma derived) | ME, arthritis, kidney disease, nerve inflammation, severe skin eruptions, eye problems | In New Zealand vaccination of babies introduced in 1988 and abandoned in early 1990’s following evidence of immune suppression; routinely offered to infants in US, but not in UK; compulsory in Italy |
VA 9 | HIB (Bacterial Meningitis caused by Haemophilus Influenzae type b) | | | introduced in US in 1985 and UK in 1992; given routinely in US at 18 months |
VA 10 | Influenza (various strains) 2 | killed organisms | encephalitis, neuritis, optic neuritis, vasulitis and joint problems, reversible paralysis, myelopathy, exacerbate asthma | |
VA 11 | Measles | live attenuated | atypical measles, Crohn’s disease, ulcerative colitis, MS, Reye’s syndrome | first introduced in UK in 1968 and in US in 1957; banned in UK in August 1999 to force parents to use MMR |
VA 12 | Meningitis | polysaccaride | | Saudi Arabia requires immunisation for those going on pilgrimage to Mecca |
| | Meningitis C | See VA 26 | | |
VA 13 | MMR (Measles, Mumps and Rubella) | live attenuated | autism, Crohn’s disease, seizures | first introduced in UK in 1988 and in US in 1975 |
VA 14 | MR (Measles and Rubella) | live attenuated | | |
VA 15 | Pertussis (Whooping Cough) | killed organisms | brain damage, asthma | first available in 1912; commonly available mid 1950’s; now mainly given as DPT; compensation for vaccine damage introduced in UK in 1978 |
VA 16 | Pneumonia | polysaccaride | | given to elderly people to prevent pneumonia |
VA 17 | Polio (Sabin) | attenuated live given orally | weight gain, Guillain-Barre syndrome, ME | in use since mid 1960’s, prior to that the Salk polio vaccine was used |
VA 18 | Polio (Salk) | killed organisms given intramuscularly | | polio vaccine first introduced in 1952/53 in US and 1956 in UK; the Sabin polio vaccine used in America and England since 1960’s; Finland, Sweden and Netherlands use this polio vaccine |
VA 19 | Rabies | killed organisms | | travel vaccination for those exposed to an unusual risk of infection e.g. taking long journeys in the bush |
VA 20 | Rubella (German Measles) | live | arthritis, polneuralgia, chronic fatigue syndrome | rubella during earlier pregnancy can result in damage to unborn child (congenital Rubella Syndrome) |
VA 21 | Smallpox | | | introduced in England in 1840 and made compulsory in 1853; it is now believed that smallpox has been eradicated so immunisation is no longer required; in USA vaccination programme stopped in 1972, but re-introduced for selected categories of people in 2003 |
VA 22 | TAB (Paratyphoid) | killed organisms | | |
VA 23 | Tetanus | inactivated bacterial toxins | | now mainly given as DPT |
VA 24 | Typhoid | killed organisms | | |
VA 25 | Yellow Fever | live attenuated | | |
VA 26 | Meningitis C | | | first used in UK in clinical trials in 1994; vaccination programme started in 1999 in UK, and from 2000 in Eire. |
VA27 | 5-In-1 Vaccine {whooping cough, diphtheria, bacterial meningitis, tetanus and polio} | | | introduced into the UK in October 2004 |
VA 28 | Pneumococcal/Prevenar | from Streptococcus pneumoniae | | protective against meningitis, septicaemia, ear infections and pneumonia. Introduced 2000 in US, 2002 in Canada, 2005 in Australia and 2006 in UK; given to children under 5 |
VA29 | Cervarix/
HPV Vaccine (Cervical Cancer Vaccination) | | | protects against HPV types 16 and 18, but no others. Used in a national immunisation programme in the UK from September 2008. |
VA30 | Gardasil /
HPV Vaccine (Cervical Cancer Vaccination) | | | licensed in over 75 countries, including Britain. It works against HPV types 16, 18, 6 and 11. |
